MedTrace Logo

Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Invasion

NCT04953468 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-07-08

No results posted yet for this study

Summary

The prognostic value of ANXA2 expression in tumor tissue and PTBE was analyzed, so as to seek new therapies to inhibit glioma invasion and improve the prognosis of glioma patients

Conditions

Interventions

DIAGNOSTIC_TEST

expression level of ANXA2 protein

The expression level of ANXA2 protein in glioma and PTBE was detected by immunohistochemistry

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Yang Jun · Peking University Third Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2022-08-01
Completion
2023-08-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953468 on ClinicalTrials.gov